With expertise in mechanotransduction and osteoarthritis, Dr. Wheeler is responsible for corporate development at Eleven Biotherapeutics. He helped found Eleven Biotherapeutics while working at Third Rock Ventures, a Boston-based venture capital firm focused on launching exceptional life sciences companies.
While at Third Rock, Dr. Wheeler gained business development and operating experience from Constellation Pharmaceuticals.
He holds a Ph.D. and S.M. in Biological Engineering and an S.B. in Mechanical Engineering from Massachusetts Institute of Technology.